Article
Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Immunology letters - 15 May 2005
Ishii Kazuo, Kurita-Taniguchi Mitsue, Aoki Mikio, Kimura Toru, Kashiwazaki Yasuo, Matsumoto Misako, Seya Tsukasa
Abstract excerpt
Adjuvants induce the expression of a number of genes in dendritic cells (DCs), which facilitate effective antigen-presentation and cytokine/chemokine liberation. It has been accepted that the toll-like receptor (TLR) family governs the adjuvant activity in DCs. An adjuvant with a long history is mycobacteria in an oil-in-water emulsion, namely Freund's complete adjuvant. Since the active center for the adjuvancy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
